There is still a debate regarding whether regimens combining irinotecan with platinum could replace regimens combining etoposide with platinum, as first-line chemotherapy for extensive-stage small cell lung cancer (ES-SCLC). | Irinotecan-platinum combination therapy for previously untreated extensive-stage small cell lung cancer patients A meta-analysis